NYSE:CL - Colgate-Palmolive Stock Price, Price Target & More

Get Started

$62.70 +0.29 (+0.46 %)

(As of 05/23/2018 12:43 PM ET)

Previous Close$62.41

Today's Range$62.23 - $63.01

52-Week Range$61.28 - $77.91

Volume1.24 million shs

Average Volume5.17 million shs

Market Capitalization$54.30 billion

P/E Ratio21.85

Dividend Yield2.70%

Beta0.75

About Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company's oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy's Oil Soap. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Toilet preparations

Sub-IndustryHousehold Products

SectorConsumer Staples

SymbolNYSE:CL

CUSIP19416210

Webwww.colgatepalmolive.comen-us

Phone212-310-2000

Debt

Debt-to-Equity Ratio64.85

Current Ratio1.08

Quick Ratio0.75

Price-To-Earnings

Trailing P/E Ratio21.85

Forward P/E Ratio19.78

P/E Growth2.46

Sales & Book Value

Annual Sales$15.45 billion

Price / Sales3.54

Cash Flow$3.4641 per share

Price / Cash18.10

Book Value$0.12 per share

Price / Book522.50

Profitability

EPS (Most Recent Fiscal Year)$2.87

Net Income$2.02 billion

Net Margins13.30%

Return on Equity1,486.69%

Return on Assets20.31%

Miscellaneous

Employees35,900

Outstanding Shares872,320,000

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive announced a quarterly dividend on Wednesday, March 7th. Stockholders of record on Friday, April 20th will be given a dividend of $0.42 per share on Tuesday, May 15th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.68%. The ex-dividend date is Thursday, April 19th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.40. View Colgate-Palmolive's Dividend History.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) released its quarterly earnings results on Friday, April, 27th. The company reported $0.74 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.73 by $0.01. The company earned $4 billion during the quarter, compared to analysts' expectations of $4.01 billion. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. The company's revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm posted $0.67 EPS. View Colgate-Palmolive's Earnings History.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, July, 20th 2018. View Earnings Estimates for Colgate-Palmolive.

What price target have analysts set for CL?

14 analysts have issued twelve-month price objectives for Colgate-Palmolive's shares. Their forecasts range from $66.00 to $85.00. On average, they anticipate Colgate-Palmolive's share price to reach $76.1818 in the next year. View Analyst Ratings for Colgate-Palmolive.

What are Wall Street analysts saying about Colgate-Palmolive stock?

Here are some recent quotes from research analysts about Colgate-Palmolive stock:

1. According to Zacks Investment Research, "Colgate has outperformed the industry in the last three months driven by smooth progress on its savings plan. The company is progressing well with its Global Growth and Efficiency Program along with additional savings anticipated from the recent expansion of the program. Moreover, the company has been infamous with investors for its meet or beat earnings track record. It also remains confident of the brand building and productivity maximization initiatives, which are likely to boost results. However, Colgate has been witnessing strained margins lately due to higher raw material and packaging costs, as well as advertising expenses. Though the company expects improved adjusted gross margin in 2018, it anticipates advertising costs to remain high, which should hurt operating margin. Moreover, it expects the backdrop to remain challenging in 2018. Nonetheless, estimates have been lately stable ahead of first-quarter 2018 earnings release." (4/17/2018)
2. Jefferies Group LLC analysts commented, "CL’s 4Q print was disappointing w/org sales of +2% (vs. +3.4% Street) and GM%/OI below expectations. 4Q EPS of $0.75 was in-line with revs/GM% miss partially offset by lower SG&A and $0.02 from taxes. FY18 guide implies tepid low-to-mid single digit % underlying EPS growth (ex-Tax Act/FX benefits), which should augment HPC group GM % worries w/higher commodity costs, constrained pricing, and need for higher investment. We expect CL’s shares to trade down." (1/26/2018)

Who are some of Colgate-Palmolive's key competitors?

Some companies that are related to Colgate-Palmolive include Estée Lauder Companies (EL), Coty (COTY), Pola Orbis (PORBF), Hypera Pharma (HYPMY), Edgewell Personal Care (EPC), Mandom (MDOMF), Inter Parfums (IPAR), Revlon (REV), Eyes Lips Face (ELF), Avon Products (AVP), United-Guardian (UG), DS Healthcare Group (DSKX) and 2050 Motors (ETFM).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the folowing people:

Ian M. Cook, Chairman of the Board, President, Chief Executive Officer (Age 64)
Daniel B. Marsili, Chief Human Resource Officer (Age 56)
John J. Huston, Senior Vice President - Chief of Staff (Age 62)
Patricia Verduin Ph.D., Chief Technology Officer (Age 58)
Mukul V. Deoras, Chief Marketing Officer (Age 53)
Henning I. Jakobsen, Vice President, Corporate Controller (Age 57)
Victoria L. Dolan, Chief Transformation Officer (Age 57)
Delia H. Thompson, Chief Investor Relations Officer (Age 67)
Makarand Karnataki, Company Secretary and Compliance Officer
Jennifer M. Daniels, Chief Legal Officer and Secretary (Age 53)

Has Colgate-Palmolive been receiving favorable news coverage?

Press coverage about CL stock has trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Colgate-Palmolive earned a media sentiment score of 0.17 on Accern's scale. They also gave news stories about the company an impact score of 47.97 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.19%), Massachusetts Financial Services Co. MA (3.34%), Northern Trust Corp (1.21%), Wells Fargo & Company MN (1.13%), First Eagle Investment Management LLC (0.90%) and OppenheimerFunds Inc. (0.73%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

Which major investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, Principal Financial Group Inc., Principal Financial Group Inc., Amundi Pioneer Asset Management Inc., State of New Jersey Common Pension Fund D, Swiss National Bank, Envestnet Asset Management Inc. and Lord Abbett & CO. LLC. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Stephen I Sadove and Victoria L Dolan. View Insider Buying and Selling for Colgate-Palmolive.

Which major investors are buying Colgate-Palmolive stock?

CL stock was purchased by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., First Eagle Investment Management LLC, BlackRock Inc., Findlay Park Partners LLP, Loomis Sayles & Co. L P, Wells Fargo & Company MN, Rockefeller Capital Management L.P. and VGI PARTNERS PTY Ltd. View Insider Buying and Selling for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $62.72.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $54.30 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]

MarketBeat Community Rating for Colgate-Palmolive (CL)

Community Ranking:		1.5 out of 5 ( )
Outperform Votes:		281 (Vote Outperform)
Underperform Votes:		683 (Vote Underperform)
Total Votes:		964

MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.

Colgate-Palmolive (NYSE:CL) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

14 Wall Street analysts have issued ratings and price targets for Colgate-Palmolive in the last 12 months. Their average twelve-month price target is $76.1818, suggesting that the stock has a possible upside of 21.50%. The high price target for CL is $85.00 and the low price target for CL is $66.00. There are currently 2 sell ratings, 9 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.07	2.13	2.13	2.24
Ratings Breakdown:	2 Sell Rating(s) 9 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 9 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 9 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 13 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$76.1818	$77.3333	$77.5833	$76.3571
Price Target Upside:	21.50% upside	10.84% upside	5.53% upside	8.38% upside

Colgate-Palmolive (NYSE:CL) Consensus Price Target History

Price Target History for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/1/2018	Citigroup	Lower Price Target	Neutral ➝ Neutral	$80.00 ➝ $73.00	Low
4/30/2018	Barclays	Set Price Target	Hold	$70.00	Low
4/30/2018	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight		Medium
4/18/2018	Stifel Nicolaus	Reiterated Rating	Hold	$75.00	Low
1/30/2018	BNP Paribas	Downgrade	Outperform ➝ Underperform		Medium
1/26/2018	Jefferies Group	Reiterated Rating	Hold	$79.00	Medium
12/19/2017	Macquarie	Upgrade	Neutral ➝ Outperform	$81.00	Low
12/13/2017	Deutsche Bank	Initiated Coverage	Hold	$75.00	Low
11/29/2017	Societe Generale	Downgrade	Hold ➝ Sell	$66.00	Medium
11/25/2017	KeyCorp	Reiterated Rating	Hold		Low
10/11/2017	SunTrust Banks	Upgrade	Hold ➝ Buy	$65.00 ➝ $85.00	N/A
10/8/2017	Royal Bank of Canada	Reiterated Rating	Hold	$74.00	N/A
7/24/2017	Wells Fargo & Co	Reiterated Rating	Market Perform		Low
5/31/2017	Bank of America	Boost Price Target	Buy	$78.00 ➝ $80.00	Low
5/2/2017	UBS	Reiterated Rating	Neutral	$79.00 ➝ $78.00	N/A
3/21/2017	JPMorgan Chase	Initiated Coverage	Neutral ➝ Neutral	$77.00	Low
2/3/2017	B. Riley	Reiterated Rating	Neutral	$74.00	N/A
1/25/2017	Berenberg Bank	Initiated Coverage	Hold	$68.00	N/A
7/29/2016	Exane BNP Paribas	Downgrade	Outperform ➝ Neutral		N/A
7/15/2016	Goldman Sachs	Reiterated Rating	Neutral	$74.00 ➝ $76.00	N/A
6/1/2016	Atlantic Securities	Initiated Coverage	Overweight		N/A

(Data available from 5/23/2016 forward)

Colgate-Palmolive (NYSE:CL) Earnings History and Estimates Chart

Earnings by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL) Earnings Estimates

2018 EPS Consensus Estimate: $3.15

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.77	$0.77	$0.77
Q2 2018	1	$0.76	$0.76	$0.76
Q3 2018	2	$0.76	$0.81	$0.79
Q4 2018	2	$0.82	$0.84	$0.83

Colgate-Palmolive (NYSE CL) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/27/2018		$0.79					N/A
4/27/2018	Q1 2018	$0.73	$0.74	$4.0137 billion	$4.0020 billion	View	N/A
1/26/2018	Q4 2017	$0.75	$0.75	$3.9204 billion	$3.8920 billion	View	Listen
10/27/2017	Q3 2017	$0.73	$0.73	$3.9425 billion	$3.9740 billion	View	N/A
7/21/2017	Q2 2017	$0.72	$0.72	$3.8908 billion	$3.8260 billion	View	N/A
4/28/2017	Q1 17	$0.66	$0.67	$3.8012 billion	$3.7620 billion	View	N/A
1/27/2017	Q416	$0.75	$0.75	$3.87 billion	$3.72 billion	View	N/A
10/27/2016	Q316	$0.73	$0.73	$3.94 billion	$3.87 billion	View	Listen
7/28/2016	Q216	$0.69	$0.70	$3.86 billion	$3.85 billion	View	Listen
4/28/2016	Q116	$0.63	$0.63	$3.76 billion	$3.76 billion	View	Listen
1/29/2016	Q415	$0.72	$0.73	$3.94 billion	$3.90 billion	View	Listen
10/30/2015	Q315	$0.72	$0.72	$4.08 billion	$4.00 billion	View	Listen
7/30/2015	Q215	$0.70	$0.70	$4.07 billion	$4.07 billion	View	Listen
4/30/2015	Q115	$0.66	$0.66	$4.06 billion	$4.07 billion	View	N/A
1/29/2015	Q414	$0.75	$0.76	$4.24 billion	$4.22 billion	View	N/A
10/24/2014	Q314	$0.75	$0.76	$4.44 billion	$4.38 billion	View	Listen
7/31/2014	Q214	$0.73	$0.73	$4.41 billion	$4.35 billion	View	N/A
4/25/2014	Q114	$0.68	$0.68	$4.32 billion	$4.33 billion	View	N/A
1/31/2014	Q413	$0.74	$0.75	$4.40 billion	$4.36 billion	View	N/A
10/24/2013	Q313	$0.73	$0.73	$4.46 billion	$4.40 billion	View	N/A
7/25/2013	Q2 2013	$0.70	$0.70	$4.39 billion	$4.35 billion	View	N/A
4/25/2013	Q1 2013	$1.32	$1.32	$4.30 billion	$4.32 billion	View	N/A
1/31/2013	Q4 2012	$1.40	$1.41	$4.31 billion	$4.29 billion	View	N/A
10/25/2012		$1.39	$1.38			View	N/A
7/26/2012		$1.33	$1.33			View	N/A
4/26/2012		$1.24	$1.24			View	N/A
1/26/2012		$1.30	$1.30			View	N/A
10/27/2011		$1.30	$1.31			View	N/A
7/28/2011		$1.25	$1.26			View	N/A
4/28/2011		$1.16	$1.16			View	N/A
1/27/2011		$1.23	$1.24			View	N/A
10/28/2010	Q3 2010	$0.60	$0.61			View	N/A
7/29/2010	Q2 2010	$0.58	$0.59			View	N/A
4/29/2010	Q1 2010	$0.58	$0.61			View	N/A
1/28/2010	Q4 2009	$0.59	$0.60			View	N/A
10/29/2009	Q3 2009	$0.56	$0.56			View	N/A
7/30/2009	Q2 2009	$0.52	$0.54			View	N/A
4/30/2009	Q1 2009	$0.49	$0.48			View	N/A
1/29/2009	Q4 2008	$0.49	$0.50			View	N/A
10/30/2008	Q3 2008	$0.49	$0.50			View	N/A
7/29/2008	Q2 2008	$0.47	$0.49			View	N/A
4/30/2008	Q1 2008	$0.44	$0.45			View	N/A
1/31/2008	Q4 2007	$0.45	$0.45			View	N/A

(Earnings results data provided by Zacks Investment Research)

Colgate-Palmolive (NYSE:CL) Dividend Information

Colgate-Palmolive pays an annual dividend of $1.68 per share, with a dividend yield of 2.68%. CL's most recent quarterly dividend payment was Tuesday, May 15. The company has grown its dividend for the last 54 consecutive years and is increasing its dividend by an average of 3.80% each year. Colgate-Palmolive pays out 58.54% of its earnings out as a dividend.

Most Recent Dividend:	5/15/2018
Annual Dividend:	$1.68
Dividend Yield:	2.68%
Dividend Growth:	3.80% (3 Year Average)
Payout Ratio(s):	58.54% (Trailing 12 Months of Earnings) 53.00% (Based on This Year's Estimates) 49.12% (Based on Next Year's Estimates) 48.50% (Based on Cash Flow)
Track Record:	54 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/7/2018	quarterly	$0.42	2.41102181400689%	4/19/2018	4/20/2018	5/15/2018
1/11/2018	quarterly	$0.40	2.12%	1/22/2018	1/23/2018	2/15/2018
9/26/2017	quarterly	$0.40	2.19%	10/20/2017	10/23/2017	11/15/2017
6/8/2017	quarterly	$0.40	2.11%	7/14/2017	7/18/2017	8/15/2017
3/9/2017	quarterly	$0.40	2.15%	4/19/2017	4/21/2017	5/15/2017
1/12/2017	quarterly	$0.39	2.37%	1/19/2017	1/23/2017	2/15/2017
9/8/2016	quarterly	$0.39	2.2%	10/20/2016	10/24/2016	11/15/2016
6/9/2016	quarterly	$0.39	2.16%	7/20/2016	7/22/2016	8/15/2016
3/10/2016	quarterly	$0.39	2.28%	4/20/2016	4/22/2016	5/16/2016
1/14/2016	quarterly	$0.38	2.4%	1/21/2016	1/25/2016	2/16/2016
9/10/2015	quarterly	$0.38	2.45%	10/21/2015	10/23/2015	11/16/2015
6/11/2015	quarterly	$0.38	2.29%	7/21/2015	7/23/2015	8/14/2015
2/19/2015	quarterly	$0.38	2.16%	4/21/2015	4/23/2015	5/15/2015
1/8/2015	quarterly	$0.36	2.1%	1/21/2015	1/23/2015	2/16/2015
9/10/2014	quarterly	$0.36	2.24%	10/15/2014	10/17/2014	11/14/2014
6/12/2014	quarterly	$0.36	2.12%	7/16/2014	7/18/2014	8/15/2014
3/13/2014	quarterly	$0.36	2.26%	4/17/2014	4/22/2014	5/15/2014
1/9/2014	quarterly	$0.34	2.09%	1/22/2014	1/24/2014	2/14/2014
9/12/2013	quarterly	$0.34	2.29%	10/18/2013	10/22/2013	11/15/2013
6/20/2013	quarterly	$0.34	2.39%	7/19/2013	7/23/2013	8/15/2013
3/7/2013	quarterly	$0.68	2.35%	4/19/2013	4/23/2013	5/15/2013
1/10/2013	quarterly	$0.62	2.32%	1/22/2013	1/24/2013	2/15/2013

(Data available from 1/1/2013 forward)

Colgate-Palmolive (NYSE CL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.02%
Institutional Ownership Percentage: 73.30%

Insider Trading History for Colgate-Palmolive (NYSE:CL)

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE CL) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/15/2018	Daniel B Marsili	Insider	Sell	19,500	$61.69	$1,202,955.00
5/15/2018	Franck J Moison	Vice Chairman	Sell	80,000	$61.75	$4,940,000.00
5/10/2018	Helene D Gayle	Director	Sell	7,000	$62.23	$435,610.00	35,395
5/10/2018	John J Huston	SVP	Sell	16,079	$62.32	$1,002,043.28	84,512
4/16/2018	Daniel B Marsili	Insider	Sell	19,500	$71.85	$1,401,075.00	77,935
2/21/2018	Daniel B Marsili	Insider	Sell	5,692	$70.19	$399,521.48	41,677
2/20/2018	Dennis J Hickey	CFO	Sell	5,651	$70.18	$396,587.18	413,221
2/20/2018	Ian M Cook	Chairman	Sell	20,891	$70.18	$1,466,130.38	1,194,619
2/20/2018	John J Huston	SVP	Sell	1,524	$70.17	$106,939.08	87,376
2/20/2018	Justin Skala	COO	Sell	4,161	$70.18	$292,018.98
2/20/2018	Mukul Deoras	CMO	Sell	2,572	$70.19	$180,528.68	39,825
2/20/2018	Patricia Verduin	CTO	Sell	1,572	$70.17	$110,307.24	50,675
2/13/2018	Franck J Moison	Vice Chairman	Sell	44,418	$69.87	$3,103,485.66	211,048
2/13/2018	John T Cahill	Director	Sell	7,000	$69.96	$489,720.00
2/12/2018	Mukul Deoras	Insider	Sell	7,150	$70.03	$500,714.50
2/9/2018	Franck J Moison	Vice Chairman	Sell	30,000	$69.70	$2,091,000.00	211,048
2/9/2018	John J Huston	SVP	Sell	14,000	$69.44	$972,160.00	100,508
2/6/2018	Franck J Moison	Vice Chairman	Sell	142,979	$70.09	$10,021,398.11	224,027
2/5/2018	Henning I Jakobsen	VP	Sell	36,215	$71.22	$2,579,232.30	70,783
1/31/2018	Ellen M Hancock	Director	Sell	4,676	$74.12	$346,585.12	208,063
1/31/2018	Noel R Wallace	COO	Sell	126,304	$73.78	$9,318,709.12	305,631
1/9/2018	Jennifer Daniels	Insider	Sell	902	$75.82	$68,389.64	37,788
12/13/2017	Jennifer Daniels	Insider	Sell	7,375	$73.18	$539,702.50	38,691
11/14/2017	Victoria L Dolan	Insider	Sell	9,000	$73.41	$660,690.00
11/10/2017	Mukul Deoras	CMO	Sell	7,500	$73.28	$549,600.00	45,217
11/9/2017	Justin Skala	COO	Sell	126,393	$72.97	$9,222,897.21	262,361
11/9/2017	Victoria L Dolan	Insider	Sell	10,000	$73.07	$730,700.00	60,528
11/6/2017	Stephen I Sadove	Director	Sell	20,780	$70.52	$1,465,405.60	36,268
8/15/2017	Patricia Verduin	Insider	Sell	3,833	$71.45	$273,867.85	53,173
8/10/2017	John J Huston	SVP	Sell	14,000	$71.36	$999,040.00	88,598
8/7/2017	Franck J Moison	Vice Chairman	Sell	35,000	$71.52	$2,503,200.00	201,411
8/3/2017	Dennis J Hickey	CFO	Sell	73,872	$71.80	$5,304,009.60	484,985
8/1/2017	Ellen M Hancock	Director	Sell	5,057	$71.91	$363,648.87	199,777
7/27/2017	John T Cahill	Director	Sell	8,000	$72.47	$579,760.00	31,786
7/27/2017	Justin Skala	COO	Sell	74,374	$72.51	$5,392,858.74	97,177
7/17/2017	Patricia Verduin	Insider	Sell	3,833	$72.41	$277,547.53	53,022
6/15/2017	Patricia Verduin	Insider	Sell	3,833	$75.67	$290,043.11	53,022
5/10/2017	John J Huston	SVP	Sell	14,000	$71.53	$1,001,420.00	102,838
5/8/2017	Richard J Kogan	Director	Sell	8,000	$71.92	$575,360.00	73,065
4/17/2017	Daniel B Marsili	VP	Sell	14,000	$73.97	$1,035,580.00	73,904
4/17/2017	Patricia Verduin	Insider	Sell	3,833	$73.72	$282,568.76	53,022
2/3/2017	Stephen I Sadove	Director	Sell	8,000	$66.00	$528,000.00	33,761
1/17/2017	Patricia Verduin	Insider	Sell	3,833	$65.99	$252,939.67	54,924
1/9/2017	Jennifer Daniels	Insider	Sell	868	$66.62	$57,826.16	36,813
12/15/2016	Patricia Verduin	Insider	Sell	3,834	$65.66	$251,740.44	54,791
12/13/2016	Jennifer Daniels	Insider	Sell	7,072	$66.78	$472,268.16	37,463
10/17/2016	Patricia Verduin	Insider	Sell	3,834	$72.39	$277,543.26	55,013
9/15/2016	Patricia Verduin	Insider	Sell	3,834	$71.85	$275,472.90	55,013
8/11/2016	Franck J Moison	COO	Sell	15,000	$75.16	$1,127,400.00	188,029
8/10/2016	John J Huston	SVP	Sell	14,000	$74.93	$1,049,020.00	102,761
8/10/2016	Richard J Kogan	Director	Sell	8,000	$74.66	$597,280.00	76,065
8/8/2016	Stephen I Sadove	Director	Sell	8,803	$74.28	$653,886.84	26,474
8/2/2016	Ellen M Hancock	Director	Sell	4,584	$74.82	$342,974.88	203,632
8/2/2016	Noel R Wallace	COO	Sell	78,849	$74.69	$5,889,231.81	236,295
7/15/2016	Patricia Verduin	CTO	Sell	3,666	$74.98	$274,876.68	54,602
6/15/2016	Patricia Verduin	CTO	Sell	3,666	$72.19	$264,648.54	54,602
5/16/2016	Patricia Verduin	CTO	Sell	3,666	$71.59	$262,448.94	54,602
5/11/2016	Ellen M Hancock	Director	Sell	4,566	$71.85	$328,067.10	199,742
5/11/2016	John J Huston	VP	Sell	14,000	$72.23	$1,011,220.00	101,843
5/11/2016	Justin Skala	COO	Sell	89,200	$72.17	$6,437,564.00	97,338
5/9/2016	Noel R Wallace	COO	Sell	8,931	$72.06	$643,567.86	155,822
5/5/2016	Delia H Thompson	VP	Sell	40,000	$72.08	$2,883,200.00	187,673
5/3/2016	John T Cahill	Director	Sell	16,000	$72.30	$1,156,800.00	28,696
5/3/2016	Noel R Wallace	COO	Sell	60,000	$72.16	$4,329,600.00	204,270
5/3/2016	Victoria L Dolan	VP	Sell	19,334	$71.76	$1,387,407.84	55,526
4/15/2016	Patricia Verduin	CTO	Sell	3,666	$70.83	$259,662.78	54,602
3/8/2016	Delia H Thompson	VP	Sell	1,698	$67.36	$114,377.28	147,673
3/8/2016	Dennis J Hickey	CFO	Sell	5,420	$67.36	$365,091.20	387,284
3/8/2016	Franck J Moison	COO	Sell	6,661	$67.36	$448,684.96	172,841
3/8/2016	Ian M Cook	CEO	Sell	25,238	$67.36	$1,700,031.68	1,281,800
3/8/2016	Mukul Deoras	CMO	Sell	1,325	$67.36	$89,252.00	46,866
3/8/2016	Noel R Wallace	Insider	Sell	5,238	$67.36	$352,831.68	126,622
3/8/2016	Patricia Verduin	CTO	Sell	1,953	$67.36	$131,554.08	50,936
2/17/2016	Dennis J. Hickey	CFO	Sell	50,697	$67.05	$3,399,233.85	392,493
2/16/2016	Fabian T. Garcia	COO	Sell	145,000	$65.72	$9,529,400.00	117,517
2/16/2016	Patricia Verduin	CTO	Sell	3,666	$66.58	$244,082.28	48,068
2/11/2016	John J. Huston	VP	Sell	14,000	$64.89	$908,460.00	86,438
2/10/2016	Richard J. Kogan	Director	Sell	8,000	$66.27	$530,160.00	68,557
2/5/2016	Delano E Lewis	Director	Sell	200	$65.92	$13,184.00	17,920
1/15/2016	Patricia Verduin	CTO	Sell	3,666	$62.37	$228,648.42	48,068
1/11/2016	Jennifer Daniels	Insider	Sell	837	$62.85	$52,605.45	36,938
8/14/2015	Ellen M Hancock	Director	Sell	3,637	$67.89	$246,915.93
6/15/2015	Daniel B Marsili	VP	Sell	14,000	$65.65	$919,100.00
6/15/2015	Patricia Verduin	CTO	Sell	3,333	$65.64	$218,778.12
5/15/2015	Delano E Lewis	Director	Sell	6,023	$68.51	$412,635.73
4/15/2015	Daniel B Marsili	VP	Sell	14,000	$69.93	$979,020.00
4/15/2015	Patricia Verduin	CTO	Sell	3,333	$69.89	$232,943.37
3/9/2015	Dennis J Hickey	CFO	Sell	18,224	$69.49	$1,266,385.76
3/9/2015	Fabian T Garcia	COO	Sell	10,137	$69.49	$704,420.13
3/9/2015	Noel R Wallace	Insider	Sell	6,638	$69.49	$461,274.62
3/9/2015	Patricia Verduin	CTO	Sell	2,828	$69.49	$196,517.72
3/9/2015	Victoria L Dolan	VP	Sell	2,834	$69.49	$196,934.66
2/10/2015	Ellen M Hancock	Director	Sell	4,011	$69.38	$278,283.18
2/10/2015	John J Huston	VP	Sell	14,000	$69.19	$968,660.00
2/5/2015	Delano E Lewis	Director	Sell	9,226	$69.05	$637,055.30
1/27/2015	Andrew D Hendry	Vice Chairman	Sell	10,000	$65.29	$652,900.00
1/15/2015	Patricia Verduin	CTO	Sell	3,333	$68.66	$228,843.78
12/23/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$70.39	$703,900.00
12/15/2014	Patricia Verduin	CTO	Sell	3,333	$68.65	$228,810.45
11/25/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$67.94	$679,400.00
11/25/2014	Larisa Harrison	Director	Buy	2,000	$0.2850	$570.00
11/17/2014	Patricia Verduin	CTO	Sell	3,333	$67.48	$224,910.84
11/11/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$68.46	$684,600.00
10/29/2014	Nigel Burton	CMO	Sell	2,323	$65.89	$153,062.47
10/28/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$66.32	$663,200.00
9/23/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$65.50	$655,000.00
9/15/2014	Patricia Verduin	CTO	Sell	3,337	$64.27	$214,468.99
9/9/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$63.52	$635,200.00
8/18/2014	Delia H Thompson	VP	Sell	40,000	$64.75	$2,590,000.00
8/18/2014	Justin Skala	Insider	Sell	41,525	$64.52	$2,679,193.00
8/8/2014	Franck J Moison	COO	Sell	24,888	$64.73	$1,611,000.24
8/5/2014	Franck J Moison	COO	Sell	41,654	$63.91	$2,662,107.14
7/22/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$68.73	$687,300.00
7/15/2014	Daniel B Marsili	VP	Sell	15,500	$69.71	$1,080,505.00
7/10/2014	Patricia Verduin	CTO	Sell	2,291	$69.66	$159,591.06
7/8/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$68.64	$686,400.00
6/24/2014	Andrew D Hendry	Vice Chairman	Sell	10,000	$67.72	$677,200.00
6/16/2014	Daniel B Marsili	VP	Sell	15,500	$67.59	$1,047,645.00
6/10/2014	Andrew D Hendry	Vice Chairman	Sell	6,000	$68.57	$411,420.00
5/27/2014	Andrew D Hendry	Vice Chairman	Sell	6,000	$66.90	$401,400.00
5/15/2014	Patricia Verduin	CTO	Sell	2,000	$66.86	$133,720.00	49,913
5/13/2014	Andrew Hendry	Vice Chairman	Sell	6,000	$67.25	$403,500.00	185,726
5/13/2014	Delano Lewis	Director	Sell	2,100	$67.19	$141,099.00	23,550
5/13/2014	Dennis Hickey	CFO	Sell	51,352	$67.18	$3,449,827.36	360,282
5/12/2014	Daniel Marsili	VP	Sell	15,500	$67.37	$1,044,235.00	75,079
5/7/2014	Stephen Fogarty	Insider	Sell	11,000	$67.23	$739,530.00	23,809
5/2/2014	Ronald Martin	VP	Sell	3,000	$67.13	$201,390.00	7,567
5/1/2014	Delano Lewis	Director	Sell	5,000	$67.07	$335,350.00	23,642
5/1/2014	Fabian Garcia	COO	Sell	122,000	$67.04	$8,178,880.00	193,936
4/22/2014	Andrew Hendry	Vice Chairman	Sell	6,000	$66.89	$401,340.00	185,726
4/15/2014	Patricia Verduin	CTO	Sell	2,000	$66.09	$132,180.00	49,913
4/8/2014	Andrew Hendry	Vice Chairman	Sell	6,000	$65.03	$390,180.00	185,726
3/17/2014	Patricia Verduin	CTO	Sell	2,000	$64.06	$128,120.00	49,913
2/28/2014	Stephen Fogarty	Insider	Sell	12,000	$63.10	$757,200.00	23,809
1/28/2014	Andrew Hendry	Vice Chairman	Sell	6,000	$62.31	$373,860.00	192,093
12/24/2013	Andrew Hendry	Vice Chairman	Sell	6,000	$64.80	$388,800.00	192,093
12/16/2013	Patricia Verduin	CTO	Sell	2,000	$64.14	$128,280.00	48,573
10/29/2013	Michael Corbo	VP	Sell	15,770	$65.00	$1,025,050.00
10/29/2013	Nigel Burton	CMO	Sell	19,862	$65.51	$1,301,159.62
10/29/2013	Stephen J Fogarty	Insider	Sell	12,000	$65.67	$788,040.00
10/22/2013	Andrew D Hendry	Vice Chairman	Sell	6,000	$62.40	$374,400.00
10/15/2013	Patricia Verduin	CTO	Sell	2,000	$61.51	$123,020.00
10/8/2013	Andrew Hendry	Vice Chairman	Sell	6,000	$59.35	$356,100.00	192,547
9/24/2013	Andrew Hendry	Vice Chairman	Sell	6,000	$60.00	$360,000.00	192,547
9/17/2013	Michael Corbo	VP	Sell	1,108	$59.62	$66,058.96	25,177
9/17/2013	Nigel Burton	CMO	Sell	2,015	$59.62	$120,134.30	45,139
9/17/2013	Patricia Verduin	CTO	Sell	3,649	$59.71	$217,881.79	48,414
9/17/2013	Stephen Fogarty	Insider	Sell	1,035	$59.62	$61,706.70	21,770
9/10/2013	Andrew D Hendry	Vice Chairman	Sell	6,000	$58.79	$352,740.00
8/15/2013	Franck Moison	COO	Sell	12,400	$60.28	$747,472.00	160,538
8/15/2013	Guillenchmidt Alec De	Insider	Sell	3,888	$60.28	$234,368.64	99,722
8/15/2013	Patricia Verduin	CTO	Sell	2,000	$60.28	$120,560.00	49,872
8/12/2013	Delia Thompson	VP	Sell	30,950	$60.73	$1,879,593.50	146,551
8/12/2013	Stephen Fogarty	Insider	Sell	12,000	$60.64	$727,680.00	22,725
8/8/2013	Nigel Burton	CMO	Sell	18,667	$61.06	$1,139,807.02	46,974
8/6/2013	Elaine Paik	VP	Sell	7,141	$60.94	$435,172.54	15,629
8/6/2013	Mukul Deoras	Insider	Sell	8,417	$60.90	$512,595.30	30,058
7/31/2013	Ronald T Martin	VP	Sell	1,800	$60.27	$108,486.00
7/30/2013	Michael Corbo	VP	Sell	10,000	$60.21	$602,100.00
7/15/2013	Franck J Moison	COO	Sell	12,400	$59.05	$732,220.00
7/15/2013	Justin Skala	Insider	Sell	4,822	$59.03	$284,642.66
7/15/2013	Michael Corbo	VP	Sell	2,000	$59.13	$118,260.00
6/17/2013	Franck J Moison	COO	Sell	12,400	$59.18	$733,832.00
6/17/2013	Guillenchmidt Alec De	Insider	Sell	3,888	$59.09	$229,741.92
6/17/2013	Michael Corbo	VP	Sell	2,000	$59.09	$118,180.00
6/4/2013	Andrew D Hendry	Vice Chairman	Sell	4,000	$58.84	$235,360.00
5/21/2013	Andrew D Hendry	Vice Chairman	Sell	6,000	$61.63	$369,780.00
5/15/2013	Franck J Moison	COO	Sell	6,200	$122.66	$760,492.00
5/15/2013	Guillenchmidt Alec De	Insider	Sell	1,944	$122.66	$238,451.04
5/15/2013	Michael Corbo	VP	Sell	1,000	$122.66	$122,660.00
5/13/2013	Rosemary Nelson	VP	Sell	14,000	$121.00	$1,694,000.00
5/10/2013	Dennis J Hickey	CFO	Sell	64,000	$120.54	$7,714,560.00
5/7/2013	Andrew D Hendry	Vice Chairman	Sell	6,000	$120.37	$722,220.00
4/30/2013	Nigel Burton	CMO	Sell	80,334	$118.68	$9,534,039.12
2/26/2013	Daniel B Marsili	VP	Sell	12,252	$113.66	$1,392,562.32
2/26/2013	Justin Skala	Insider	Sell	5,894	$113.64	$669,794.16
12/4/2012	Andrew D Hendry	Vice Chairman	Sell	6,000	$108.00	$648,000.00
10/2/2012	Andrew D Hendry	Vice Chairman	Sell	6,000	$108.27	$649,620.00
9/4/2012	Andrew D Hendry	Vice Chairman	Sell	6,000	$106.16	$636,960.00

(Data available from 1/1/2013 forward)

Colgate-Palmolive (NYSE CL) News Headlines

Source:

Date	Headline
	Free Research Report as Colgate-Palmolive’s Sales Rose 6.5%; Adjusted EPS Jumped 10% finance.yahoo.com - May 23 at 8:31 AM
	Brokerages Anticipate Colgate-Palmolive (CL) Will Post Quarterly Sales of $4.02 Billion www.americanbankingnews.com - May 21 at 2:50 AM
	Analysts Anticipate Colgate-Palmolive (CL) Will Post Earnings of $0.79 Per Share www.americanbankingnews.com - May 19 at 3:31 PM
	Colgate-Palmolive Webcasts Presentation At The Bernstein 34th Annual Strategic Decisions Conference finance.yahoo.com - May 17 at 5:59 PM
	Colgate-Palmolive (CL) Receives Consensus Recommendation of "Hold" from Brokerages www.americanbankingnews.com - May 17 at 5:37 PM
	Insider Selling: Colgate-Palmolive (CL) Insider Sells 19,500 Shares of Stock www.americanbankingnews.com - May 16 at 7:32 PM
	Colgate-Palmolive (CL) Vice Chairman Franck J. Moison Sells 80,000 Shares www.americanbankingnews.com - May 16 at 7:16 PM
	Why Investors Aren’t Generous on PG, KMB, CL, and CLX finance.yahoo.com - May 16 at 5:21 PM
	PG, KMB, CL, and CLX: What’s behind Rising Dividend Yields? finance.yahoo.com - May 16 at 5:21 PM
	Why Colgate’s Improving Trends Failed to Impress Investors finance.yahoo.com - May 16 at 5:21 PM
	John J. Huston Sells 16,079 Shares of Colgate-Palmolive (CL) Stock www.americanbankingnews.com - May 14 at 7:41 PM
	Insider Selling: Colgate-Palmolive (CL) Director Sells 7,000 Shares of Stock www.americanbankingnews.com - May 14 at 7:40 PM
	Colgate-Palmolive Brushes Up On-Shelf Availability Strategy to Rule the Shelf www.prnewswire.com - May 14 at 5:09 PM
	Colgate-Palmolive: A Consumer Defensive Heavyweight seekingalpha.com - May 14 at 5:09 PM
	Citi Cuts Colgate-Palmolive (CL) PT After Reviewing the 10-Q www.streetinsider.com - May 9 at 8:36 AM
	BRIEF-Colgate-Palmolive Co Appoints Henning Jakobsen As CFO www.reuters.com - May 4 at 5:15 PM
	Colgate-Palmolive (CL) Names Henning Jakobsen as CFO and Dennis Hickey as Vice Chairman www.streetinsider.com - May 4 at 5:15 PM
	Colgate names company veteran as chief financial officer finance.yahoo.com - May 4 at 5:15 PM
	Colgate Appoints Henning Jakobsen as Chief Financial Officer and Dennis Hickey as Vice Chairman finance.yahoo.com - May 4 at 5:15 PM
	$4.03 Billion in Sales Expected for Colgate-Palmolive (CL) This Quarter www.americanbankingnews.com - May 4 at 4:40 AM
	ValuEngine Lowers Colgate-Palmolive (CL) to Sell www.americanbankingnews.com - May 2 at 11:35 PM
	$0.80 Earnings Per Share Expected for Colgate-Palmolive (CL) This Quarter www.americanbankingnews.com - May 2 at 3:20 AM
	What’s behind Colgate-Palmolive’s 1Q18 Earnings Beat? finance.yahoo.com - May 1 at 5:06 PM
	Colgate-Palmolive (CL) Price Target Cut to $73.00 by Analysts at Citigroup www.americanbankingnews.com - May 1 at 10:42 AM
	Colgate-Palmolive (CL) Given a $70.00 Price Target by Barclays Analysts www.americanbankingnews.com - May 1 at 10:01 AM
	Morgan Stanley Shifts To Neutral On Colgate-Palmolive, Cites Emerging Markets Weakness www.benzinga.com - April 30 at 5:03 PM
	Colgate-Palmolive Webcasts Presentation at its 2018 Annual Meeting of Stockholders May 11, 2018 – 10:00 a.m. ET finance.yahoo.com - April 30 at 5:03 PM
	Colgate-Palmolive (CL) Stock Rating Lowered by Morgan Stanley www.americanbankingnews.com - April 30 at 10:04 AM
	Morgan Stanley Downgrades Colgate-Palmolive Company (CL) to Equalweight www.streetinsider.com - April 30 at 8:39 AM
	Colgate-Palmolive Company (CL) Q1 2018 Earnings Conference Call Transcript finance.yahoo.com - April 28 at 8:50 AM
	Edited Transcript of CL earnings conference call or presentation 27-Apr-18 3:00pm GMT finance.yahoo.com - April 28 at 8:50 AM
	Charts of the Day: Colgate-Palmolive, Expedia, Sprint finance.yahoo.com - April 27 at 5:05 PM
	Earnings Reaction History: Colgate-Palmolive, 50.0% Follow-Through Indicator, 2.3% Sensitive www.nasdaq.com - April 27 at 5:05 PM
	Colgate-Palmolive Q1 18 Earnings Conference Call At 11:00 AM ET www.nasdaq.com - April 27 at 5:05 PM
	Colgate-Palmolive (CL) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS www.americanbankingnews.com - April 27 at 2:56 PM
	Colgate-Palmolive Company Stock Reports Disappointing Sales for Q1 investorplace.com - April 27 at 11:54 AM
	BRIEF-Colgate Announces Q1 Earnings Per Share $0.72 www.reuters.com - April 27 at 8:50 AM
	Colgate Announces 1st Quarter 2018 Results finance.yahoo.com - April 27 at 8:50 AM
	Colgate-Palmolive shares decline 2% after Q1 revenue miss finance.yahoo.com - April 27 at 8:50 AM
	Colgate-Palmolive: 1Q Earnings Snapshot finance.yahoo.com - April 27 at 8:50 AM
	Stocks making the biggest moves premarket: CL, MCO, SNE, AMZN, MSFT, INTC, SBUX & more finance.yahoo.com - April 27 at 8:50 AM
	[$$] Colgate sales growth fails to shine finance.yahoo.com - April 27 at 8:50 AM
	Colgate's sales disappoint on tepid emerging market demand finance.yahoo.com - April 27 at 8:50 AM
	Colgate-Palmolive (CL) call put ratio 5.8 calls to 1 put into EPS and outlook www.streetinsider.com - April 26 at 8:30 AM
	Why Colgate-Palmolive (CL) Might Surprise This Earnings Season www.nasdaq.com - April 25 at 5:18 PM
	Colgate-Palmolive Enters Oversold Territory (CL) www.nasdaq.com - April 25 at 5:18 PM
	Colgate-Palmolive (CL) call put ratio 1 call to 6 puts with focus on April 67 puts into Q1 www.streetinsider.com - April 24 at 8:34 AM
	What Analysts Recommend For Church & Dwight Stock finance.yahoo.com - April 23 at 5:02 PM
	20 Earnings Reports to Watch for This Week finance.yahoo.com - April 23 at 8:27 AM
	Does Colgate-Palmolive Company’s (NYSE:CL) PE Ratio Signal A Selling Opportunity? finance.yahoo.com - April 22 at 6:20 PM

Colgate-Palmolive (NYSE:CL) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Colgate-Palmolive (NYSE:CL) Income Statement, Balance Sheet and Cash Flow Statement

Colgate-Palmolive (NYSE CL) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff